World High Life Subsidiary Discusses Product Development, Brand Ambassador, Georges St-Pierre, and New Brands
World High Life (OTCQB: WRHLF) and its wholly owned subsidiary, Love Hemp, a London-based CBD company spearheading the development of the United Kingdom’s (UK) leading range of trusted CBD products, have been keeping customers coming back at a record pace in 2020. With over 80 products to offer consumers, including oils, sprays, edibles, cosmetics, and vapes, and around 1,200 retail listings, Love Hemp is just getting started.
Product development is the lifeblood of any company, and Love Hemp’s Chief Executive Officer, Tony Calamita, has always said it’s at the heart of everything the company does to provide value for customers and meet what is an ever-increasing demand for the company’s offerings. Stock Market Media Group, a news & media content development investor relations firm, caught up with Tony Calamita to discuss the company’s expansive product development pipeline, newly launched brands, and its use of 3-time MMA World Champion, Georges St-Pierre, as its brand ambassador and the potential to include the popular fighter in future product development.
SMMG: With Love Hemp Immune and Buzz Leaf brands already hitting the market in 2020, can you explain the thinking around the development of these two products?
Tony Calamita: “It can take up to 18 months to see a product move from concept to being shelf ready. ‘Love Hemp Immune’ was developed in late 2019 with the aim of launching it in the Winter of 2020, at a time when the flu season is typically at its peak in the UK and throughout Europe. However, we fast-tracked its launch to early February 2020 in order to support our consumers through the COVID-19 pandemic.
“CBD has many benefits for multiple consumer groups across a variety of daily consumption occasions. With ‘Buzz Leaf’ we wanted to develop a brand that had more freedom as it relates to the product categories it could be included within, from vapes to full spectrum CBD oils, capsules and other products. We also wanted to target a younger demographic in order to grow our market share. As a result, Buzz Leaf was developed in mid-2019, and we launched it to our consumers in early 2020.”
SMMG: Can you talk about the reaction from consumers regarding both the Love Hemp Immune and Buzz Leaf brands?
Tony Calamita: “Due to the unforeseen impact of COVID-19, we decided, as a brand, to ensure our Love Hemp Immune product range was accessible to everyone. As a result, we launched the atomizer spray and capsule format at a special price to ensure everyone had the ability to boost their natural immune systems. In turn, the reaction from consumers has been overwhelmingly positive, and has helped to elevate our standing with both new and existing consumers.
“Since its launch in mid-July, Buzz Leaf has also seen a positive growth curve. We have new marketing initiatives planned for later this year to support the brand and to further accelerate its growth curve.”
SMMG: How many current products do you have in development, and how do you decide when to launch these new products?
Tony Calamita: “At any one time, it’s possible for us to have up to 30 products under consideration. When planning the launch of any new product, we look at the global CBD market, and more specifically, we look at markets that we trade or plan to trade within in the future. These markets include North America, Europe, Asia and the Middle East. We consult with our retail customers and listen to consumer feedback while monitoring the shifts and trends in market dynamics.”
SMMG: What can the CBD market expect from Love Hemp in the near future in the way of new product development?
Tony Calamita: “We have a number of new products currently in development for the North American, Canadian and Asian markets. At the same time, we’ve also recently launched our first vegan supplement range – Love Hemp Life+.”
SMMG: Love Hemp’s Brand Ambassador, 3-time MMA World Champion, Georges St-Pierre, continues to be a wildly popular figure in the MMA—do you have any plans to design any future brands or have any future product campaigns with him in mind?
Tony Calamita: “Georges St-Pierre is a significant brand ambassador for Love Hemp. With sports professionals turning to CBD for myriad reasons, a long-term partnership with Georges St-Pierre was a natural fit, and we look forward to working closely with him on marketing initiatives that could include potential ranges around sports nutrition.”
SMMG: What prompted the company to begin the expansion of a multi-level production facility?
Tony Calamita: “Our primary reason for the expansion of our production facility is the significant growth of CBD in both the UK and European markets, which is being driven by major retailers showing significant interest in new listings. The expansion further increases our capability of always exceeding customer and consumer requirements while improving production capabilities and lead times, along with continuing to ensure the health, safety and well-being of our staff.”
SMMG: When can the market expect the next new brand to be announced?
Tony Calamita: “In early 2020, we launched three new CBD brands to consumers. We have also just launched our first non-CBD range of vegan supplements – ‘Love Hemp Life+,’ which will be our primary focus for the next quarter, as consumer demand for holistic health and well-being continues to increase. Love Hemp Life+ offers a diverse range of natural supplements, to help enhance the daily well-being of everyday consumers.”
Love Hemp is doing just about everything right in 2020 and is certainly setting one sales record after another with each successive month and quarter, but what is most exciting about where Love Hemp is heading is the company’s ability to continue to develop a wide-ranging pipeline of products with both the market and its consumers in mind.
To learn more about Love Hemp visit: https://www.love-hemp.com
To learn more about the new Buzz Leaf product line visit: https://www.cbdoilsuk.com
For direct questions, call their toll-free number in North America: 1-888-616-9745
About World High Life
World High Life PLC is an investment company with a strategic focus to invest in and/or acquire companies operating in the CBD wellness and medicinal cannabis industry. The Company’s wholly owned subsidiary, Love Hemp Ltd., is one of the UK’s leading CBD and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products. Love Hemp has established relationships with over 1,200 stores in the UK, including leading brands such as Ocado, Holland & Barrett, and WH Smith.
About Stock Market Media Group
Stock Market Media Group is a news & media content development IR firm offering a platform for corporate stories to unfold in the media with press releases, research reports, corporate videos, radio-style CEO interviews, and feature news articles.
This article was written based on publicly available information. Stock Market Media Group may, from time to time, include our own opinions about the companies, their business, markets and opportunities in our articles. Any opinions we may offer about any of the companies we write about are solely our own and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any of the securities we write about are solely your responsibility based on your own due diligence. Our publications are provided only as an informational aid, and as a starting point for doing additional independent research. We encourage you to invest carefully and read the investor information available at the web site of the U.S. Securities and Exchange Commission at www.sec.gov, where you can also find all of World High Life’s filings and disclosures. We also recommend, as a general rule, that before investing in any securities, you consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks. We are not a registered broker, dealer, analyst, or advisor. We hold no investment licenses and may not sell, offer to sell, or offer to buy any security. Our publications about World High Life are not a recommendation to buy or sell a security.
Should Stock Market Media Group and its management own shares in the profiled company, they may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the company’s profile. Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment. Under the Securities Act of 1933, Section 17(b), Stock Market Media Group discloses that it was remunerated one-thousand, two hundred dollars paid for by a third party via bank wire, to produce this content related to World High Life.
Stock Market Media Group and its management do not own any shares in World High Life and never accepts compensation in free-trading shares for its marketing services of the company being profiled, however third parties that have compensated Stock Market Media Group may hold free-trading shares of the company being profiled and could very well be selling, holding or buying shares of the company’s stock at the same time the content is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
If Stock Market Media Group ever accepts compensation in the form of free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the company’s profile, our disclaimer will be updated accordingly to reflect the current position of any free trading shares received as compensation for our services.
For more information: www.stockmarketmediagroup.com
Stock Market Media Group email@example.com
News Provided by GlobeNewswire via QuoteMedia
Love Hemp Group PLC
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.